FIGULRE LEGENDS
Figure 1. (A–C) Microscopic images of bone marrow smears at onset. Blasts were negative for MPO and 2–3 times the size of small lymphocytes with a 60–90% nucleus-to-cytoplasm ratio, delicate chromatin, irregular nuclear contours, prominent nucleoli, and no cytoplasmic granules. (A) May-Giemsa-stained sample; magnification, ×200. (B) May-Giemsa-stained sample; magnification, ×1000. (C) MPO-stained sample; magnification, ×400. (D–F) Flow cytometric analysis before administration of InO, showing a population of blasts expressing surface CD22 and dim CD45, but lacking CD19.
Figure 2. Clinical course until day +100 post transplantation. PIR, pre-engraftment immune reaction; GVHD, graft-versus-host disease; VOD, veno-occlusive disease; SOS, sinusoidal obstruction syndrome; rhTM, recombinant human soluble thrombomodulin; MTX, methotrexate; mPSL, methylprednisolone; PSL, prednisolone; TAC, tacrolimus.